This country profile provides an overview of Niger’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
65%
Blinding trachoma
63%
Intestinal worms
73%
Bilharzia
100%
River blindness
N/A
11.19 million
people received treatment in Niger in 2019
2.86 million
people did not receive treatment in Niger in 2019
Elephantiasis
Treatment coverage decreased from 74% in 2018 to 65% in 2019.
People needing treatment
6.68m
People receiving treatment
4.33m
Blinding trachoma
Treatment coverage increased from 18% in 2018 to 63% in 2019.
People needing treatment
5m
People receiving treatment
3.15m
Intestinal worms
Treatment coverage decreased from 76% in 2018 to 73% in 2019.
Pre-sch and school-aged children needing treatment
10.39m
Pre-school and school-aged children receiving treatment
7.54m
Bilharzia
Treatment coverage remained at 100% in 2018 and 2019.
School-aged children needing treatment
2.61m
School-aged children receiving treatment
2.61m
River blindness
Niger does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Niger.